Combination of pulse methylprednisolone infusions with cyclosporine-based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation

Clinical Transplantation

Volumn 27, Issue 2, 2013, Pages

  Shishido, Seiichiro ^a   Satou, Hiroyuki ^b   Muramatsu, Masaki ^a   Hamasaki, Yuko ^a   Ishikura, Kenji ^b   Hataya, Hiroshi ^b   Honda, Masataka ^b   Asanuma, Hiroshi ^c   Aikawa, Atsushi ^a  

^a TOHO UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

Children; Focal segmental glomerulosclerosis; Kidney transplantation; Nephrotic syndrome; Recurrence

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; ADULT; ARTICLE; BONE DEMINERALIZATION; CATARACT; CHILD; CLINICAL ARTICLE; CONVALESCENCE; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG SAFETY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; GROWTH RETARDATION; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; KIDNEY TRANSPLANTATION; MALE; OLIGURIA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; RELAPSE; REMISSION; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; POSTOPERATIVE COMPLICATIONS; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876083890     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12079     Document Type: Article

References (28)

1. Baum MA. Outcomes after renal transplantation for FSGS in children. Pediatr Transplant 2004: 8: 329.
2. Tejani A, Stablein DH. Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. Am Soc Nephrol 1992: 2(12 Suppl): S258.
3. Dall'Amico R, Ghiggeri G, Carrazo M et al. Prediction and treatment of recurrent FSGS after renal transplantation in children. Am J Kidney Dis 1999: 34: 1048.
4. Hubsch H, Montané B, Abitbol C et al. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience. Pediatr Nephrol 2005: 20: 210.
5. Abbott KC, Sawyers ES, Oliver JD 3rd et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001: 37: 366.
6. Fine RN. Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol 2007: 22: 496.
7. Percovitz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituxiab treatment. N Engl J Med 2006: 354: 1961.
8. Dell Strologo L, Guzzo I, Laurenzi C et al. Use of rituximab in focal segmental glomerulosclerosis relapses after renal transplantation. Transplantation 2009: 88: 417.
9. Baum MA, Stablein DM, Panzarino VM, Tejani A, Harmon WE, Alexander SR. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001: 59: 328.
10. Jungraithmayr T, Clara A, Zimmerhackl L. Recurrence of focal segmental glomerulosclerosis (FSGS) after renal transplantation: results of the European Collaborative FSGS transplantation study group (ECOFTS). Pediatr Transplant 2005: 6: 48.
11. Davenport RD. Apheresis treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation: re-analysis of published case-report and case-series. J Clin Apheresis 2001: 16: 175.
12. Mahesh S, Del Rio M, Feuerstein D et al. Demographic and response to therapeutic plasma exchange in pediatric renal transplantation for focal glomerulosclerosis: a single center experience. Pediatr Transplant 2008: 12: 682.
13. Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM. Treatmentof steroid-resistant focal segmental glomerulosclerosis with pulse methylpredonisolone and alkylating agents. Pediatr Nephrol 1990: 4: 303.
14. Tune BM, Kirpekar R, Siblley RK, Reznik VM, Griswold WR, Mendoza SA. Intravenous methylpredonisolone and oral alkylating agent therapy of presonisone-resistent pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 1995: 43: 84.
15. Kirpekar R, Yorgin PD, Tune BM, Kim MK, Sibley RK. Clinicopathologic correlates predict the outcome in children with steroid-resistant idiopathic nephrotic syndrome treated with pulse methylpredoisolone therapy. Am J Kidney Dis 2002: 39: 1143.
16. Meyrier A. Treatment of focal segmental glomerulosclerosis. Expert Opin Pharmacother 2005: 6: 1539.
17. Waldo FB, Benfield MR, Kohaut EC. Methylpredonisolone treatment of patients with steroid-resistant nephrotic syndrome. Pediatr Nephrol 1992: 6: 503.
18. Ingulli E, Singh A, Baqi N, Almad H, Moazami S, Tejani A. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc Nephrol 1995: 5: 1820.
19. Sairam VK, Kalia A, Rajaraman S, Travis LB. Secondary resistance to cyclosporine in children with nephrotic syndrome. Pediatr Nephrol 2002: 17: 842.
20. Salomon R, Gagnadoux M, Niaudet P. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 2003: 75: 810.
21. Raafat RH, Kalia A, Travis LB. Diven SC. High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis 2004: 44: 50.
22. Faul C, Donnelly M, Mersher-Gomez S et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008: 14: 931.
23. Jabs K, Sullivan EK, Avner ED, Hamons WE. Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1996: 61: 31.
24. Ingulli E, Tejani A. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children-a single-center experience. Transplantation 1991: 51: 401.
25. Crosson JT. Focal segmental glomerulosclerosis and renal transplantation. Transplant Proc 2007: 39: 737.
26. Gohh RY, Yango AF, Morrissey PE et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 2005: 5: 2907.
27. Hattori M, Akioka Y, Chikamoto H et al. Increase of integurin-linked kinase activity in cultured podocytes upon stimulation with plasma from patients with recurrent FSGS. Am J Transplant 2008: 8: 1550.
28. Fornoni A, Sageshima J, Wei C et al. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 2011: 3: 1.